SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-007060
Filing Date
2024-05-07
Accepted
2024-05-07 16:15:50
Documents
16
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20240507x8k.htm   iXBRL 8-K 36407
2 EX-99.1 armp-20240507xex99d1.htm EX-99.1 160880
3 GRAPHIC armp-20240507xex99d1001.jpg GRAPHIC 2307
  Complete submission text file 0001558370-24-007060.txt   338888

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20240507.xsd EX-101.SCH 4021
5 EX-101.DEF armp-20240507_def.xml EX-101.DEF 2856
6 EX-101.LAB armp-20240507_lab.xml EX-101.LAB 16591
7 EX-101.PRE armp-20240507_pre.xml EX-101.PRE 10915
19 EXTRACTED XBRL INSTANCE DOCUMENT armp-20240507x8k_htm.xml XML 4610
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 24922102
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)